Sun, 25 Oct 2026
Pharma in Focus

Connecting you with your industry every day

Featured

Ex-Aussie GM nabs top job with newcomer

This well-known boss is back in Australia and leading the region for a company that's chasing approvals globally for a drug that's been hailed a game-changer

Leadership & People

Pharma boss smashes two glass ceilings

Inducted into the Hall of Fame as a "pioneer of breaking glass ceilings" in both gender and age, this pharma leader has been honoured for her vision and courage

Industry & Companies

Arrotex signs deal for locally-developed med

Agreement brings together innovative anti-infective development platform and the Aussie giant's established regulatory, market access and commercial capabilities

Awards

LinkedIn names Australia's best workplaces

Healthtech has emerged as a major force in this year’s LinkedIn Top Startups Australia list, an annual ranking of the emerging companies where professionals want to work

Pipeline & Intellectual Property

Aussies tapped for US gene project

UQ researchers selected to help the US produce personalised genetic therapies in hospitals to deliver RNA medicines to patients within days of diagnosis, instead of months

Latest

BioNTech opens Aussie mRNA facility

World-class facility in Melbourne will help deliver the next generation of life-changing treatments in cancer, heart disease, and neurological and autoinflammatory diseases

Regulation & Legal

CSL slapped with investor class action

A lawsuit has been filed by investors who bought shares during a calamitous price plunge but CSL has promised to 'vigorously' defend all accusations

Latest News
Industry & Companies

Time-poor doctors move from papers to podcast

An Australian company is helping time-poor doctors stay up to speed with the latest research by turning clinical papers into podcasts with pharmas on board as sponsors

Industry & Companies

Takeover sends shares tumbling by 34%

This ASX-listed company has increased its stake to own two-thirds of a joint venture started two years ago but investors are not impressed

Industry & Companies

Aussie industry mega-event in full swing

Three flagship events brought together by AusBiotech for the first time is underway on the Gold Coast with more than 2500 expected to attend

Featured

CSL names ex-Aussie GM as new CEO

After a global search, CSL has picked a former Aussie GM and a 'world-class, purpose-driven' high-flyer from a rival pharma to be its fourth CEO

Other News
Patients

Aussie patient groups speak up on pricing

New website reveals that Australian patients are among the most active in the world when it comes to taking their case for medicines access to drug-pricing regulators

Regulatory & Reimbursement

15 drugs jostle for November PBS listings

Among the 15-strong list are nine drugs vying to become the first to secure subsidy after being recommended at the PBAC's July 2026 meeting

All positions →

Jobs

  1. Principal Investigator - Clinical Research | Clinical Trials Doctor New

    HPGWollongongClinical
  2. Pharmaceutical Sales Representative New

    HPGBrisbaneSales
  3. Pharmacovigilance Manager New

    HPGSydneyClinical
  4. Senior Territory Manager - Pharmacy QLD New

    HPGBrisbaneSales
  5. Warehouse Assistant & Forklift Driver New

    HPGLane Cove WestOther
  6. Territory Manager New

    HPGChristchurchSales
  7. National Sales Manager New

    HPGAucklandSales
  8. Regional Sales Manager New

    HPGSydneySales
  9. Clinical Data Manager New

    HPGRandwickClinical
  10. Corporate Accounts Lead New

    HPGSydneySales
Earlier News
Government & Policy

Trump splurges on Big Pharma shares

The US President has come under scrutiny after boosting his pharma shareholdings by a breathtaking 3000 per cent last year. Find out which companies he's invested in

Regulatory & Reimbursement

PBAC tweaks November Agenda

One submission withdrawn, a couple of newcomers join the list and a potentially eye-opening DUSC analysis deferred as PBAC readies for its next meeting in a fortnight

Regulatory & Reimbursement

Rare disease drugs head for Australia

The TGA has handed out eight orphan drug designations in the past quarter, with three of them targeting the same kidney disease.

In Case You Missed It
Regulatory & Reimbursement

Sept PBAC: Winners and Losers

Two out of three companies hoping to cut a path to a broad listing were told the preliminary info they provided didn't cut it, according to outcomes from September's Intracycle Meeting

More News